Tabka M, Frioui R, Berardi G, Mouffak A, et al. A new adverse drug reaction - pigmented purpuric dermatosis caused by osimertinib administration - a case report. Int J Dermatol 2022 May 14. doi: 10.1111/ijd.16291.
PMID: 35567510